Biopharmaceutical company AstraZeneca has received more than $1 billion in funding from BARDA for the development, production and delivery of Oxford University's vaccine for COVID-19.

Understood as a virtual army in the war against COVID-19, AI has vast stockpiles of potential weaponry with which to wage many a battle. That’s the good news.

Testing all residents and staff at the nation’s nursing homes just once would collectively cost $440 million, according to data from the American Health Care Association and National Center of Assisted Living (AHCA/NCAL).

CMS has issued a plan to reopen the nation’s nursing homes with a new guidance for state and local officials.

CVS Health has stated it will return $43 million in funding it received for COVID-19 relief.

COVID-19 isn’t only keeping patients home when they should be seeing their doctors. It’s also keeping clinical investigators from moving ahead with their research.

The lab’s leaders are pledging to support innovators in various industries—including healthcare—who will have a hand in the rise of 5G technology.

Clinicians equipped with machine learning can, in theory, apply what works for one patient to the care of another—and another, and another—and so on.

Hospitals and healthcare providers are facing higher costs to care for complex COVID-19 patients while also suffering the loss of other procedures like elective surgeries that could help offset these higher costs.

Civica Rx has teamed up with the U.S. government to aid in the COVID-19 response.